JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1991; 17:458-460
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, K.
Right arrow Articles by Freedom, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, K.
Right arrow Articles by Freedom, R.

Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial

KY Chan, M Iwahara, LN Benson, GJ Wilson, and RM Freedom

Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

To assess whether steroid therapy influenced the clinical course of myocarditis in a pediatric population, findings in 13 consecutive infants and children (8 female, 5 male) with biopsy-proved myocarditis were reviewed. The mean age was 5.7 +/- 4.8 years (range 1.1 to 14.8). Congestive heart failure was present in all as were ST-T wave changes, cardiomegaly and pulmonary edema on chest roentgenogram. Echocardiography demonstrated pericardial effusion in five patients and mitral regurgitation in eight. Mean left ventricular ejection fraction was 34 +/- 12%. Prednisone was administered to all patients; one patient also received azathioprine. There was one death. All survivors showed clinical improvement with normalization of ECG changes, heart size and systolic function. No significant side effects occurred. Repeat myocardial biopsy in eight patients demonstrated improvement in all eight and elimination of the inflammatory infiltrate in six. Immunosuppressive therapy in this pediatric population appeared useful in improving the clinical course and cardiac function in acute myocarditis with no adverse side effects.


This article has been cited by other articles:


Home page
HeartHome page
M Burch
Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence
Heart, October 1, 2004; 90(10): 1103 - 1104.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
C P P Hia, W C L Yip, B C Tai, and S C Quek
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review
Arch. Dis. Child., June 1, 2004; 89(6): 580 - 584.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. E. R. Martin, J. L. Moya-Mur, M. Casanova, A. Crespo-Diez, E. Asin-Cardiel, J. M. Castro-Beiras, L. Diez-Jimenez, M. Ballester, I. Carrio, and J. Narula
Role of Noninvasive Antimyosin Imaging in Infants and Children with Clinically Suspected Myocarditis
J. Nucl. Med., March 1, 2004; 45(3): 429 - 437.
[Abstract] [Full Text]


Home page
Eur Heart J SupplHome page
A. Frustaci, M. Pieroni, and C. Chimenti
Immunosuppressive therapy in inflammatory cardiomyopathy
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I69 - I72.
[Abstract] [PDF]


Home page
ChestHome page
A. Frustaci, F. Calabrese, C. Chimenti, M. Pieroni, G. Thiene, and A. Maseri
Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy
Chest, October 1, 2002; 122(4): 1348 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. E. Nield, E. D. Silverman, J. F. Smallhorn, G. P. Taylor, J. Brendan, M. Mullen, L. N. Benson, and L. K. Hornberger
Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 796 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. W. Duncan, D. J. Bohn, A. M. Atz, J. W. French, P. C. Laussen, and D. L. Wessel
Mechanical circulatory support for the treatment of children with acute fulminant myocarditis
J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 440 - 448.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Frustaci, C. Chimenti, and A. Maseri
Global Biventricular Dysfunction in Patients With Asymptomatic Coronary Artery Disease May Be Caused by Myocarditis
Circulation, March 16, 1999; 99(10): 1295 - 1299.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
A. K. Shetty
A Child with Chest Pain
Clinical Pediatrics, May 1, 1998; 37(5): 317 - 319.
[PDF]


Home page
CirculationHome page
M. Kodama, S. Zhang, H. Hanawa, M. Saeki, T. Inomata, K. Suzuki, S. Koyama, and A. Shibata
Effects of 15-Deoxyspergualin on Experimental Autoimmune Giant Cell Myocarditis of the Rat
Circulation, February 15, 1995; 91(4): 1116 - 1122.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
G. M. Folger JR, E. A. Eltohami, and H. A. Hajar
Acute Myocardial-Infarction-Like Findings with Myocarditis in Infancy: A Case Report
Angiology, August 1, 1994; 45(8): 737 - 741.
[Abstract] [PDF]


Home page
CirculationHome page
L. E. Nield, E. D. Silverman, G. P. Taylor, J. F. Smallhorn, J. B. M. Mullen, N. H. Silverman, J. P. Finley, Y. M. Law, D. G. Human, P. G. Seaward, et al.
Maternal Anti-Ro and Anti-La Antibody-Associated Endocardial Fibroelastosis
Circulation, February 19, 2002; 105(7): 843 - 848.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1991 by the American College of Cardiology Foundation.